beta

ADMP

Adamis Pharmaceuticals Corp.

Admp

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Adamis Pharmaceuticals Corp. is a biopharmaceutical company, which engages in the discovery, development and sales of pharmaceutical, specialty biopharmaceutical and other drug products. It offers Symjepi product for allergy, respiratory, opioid overdose, and erectile dysfunction (ED), markets. The company was founded in June 2006 and is headquartered in San Diego, CA.

Market Cap: 32.7 Million

Primary Exchange: NASDAQ

Website: http://www.adamispharmaceuticals.com

Shares Outstanding: 61.6 Million

Float: 58.7 Million

Dividend: (%)

Beta: 0.684160718035853

Sector: Health Technology

Industry: Pharmaceuticals: Other

Ethical Flags

Animal testing

Longest drawdown: 1735 trading days

From: 2013-02-12 To: 2019-12-09

Lowest Point:

Adamis: Share Price Continues To Grind Down To A Fine Discount

via: SeekingAlpha at 2019-06-13 04:24:20:000

Adamis Pharmaceuticals ( ADMP ) is a specialty biopharmaceutical company dedicated to developing and commercializing various therapeutic products. The company's leading product, SYMJEPI, is a pre-filled syringe "PFS" device holding 0.3mg or 0.15mg dosage of epinephrine that has FDA approval fo… read more...

Adamis amends U.S. application for higher dose naloxone, hopes for speedy approval

via: SeekingAlpha at 2019-06-11 07:39:43:000

Based on FDA feedback, Adamis Pharmaceuticals ( ADMP -4.5% ) has removed kalo's EVZIO (naloxone HCl injection) 2 mg auto-injector as the Reference Listed Drug (RLD) in its marketing application seeking approval for its higher dose naloxone injection product for the emergency trea… read more...

Adamis amends U.S. application for higher dose naloxone, hopes for speedy approval

via: SeekingAlpha at 2019-06-11 07:39:43:000

Based on FDA feedback, Adamis Pharmaceuticals ( ADMP -4.5% ) has removed kalo's EVZIO (naloxone HCl injection) 2 mg auto-injector as the Reference Listed Drug (RLD) in its marketing application seeking approval for its higher dose naloxone injection product for the emergency trea… read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
2013-12-13 17.0 1.0 17.0
Data provided by IEX Cloud